Cargando…

Updating the evidence on drugs to treat overactive bladder: a systematic review

INTRODUCTION: Overactive bladder (OAB) is a common condition, increasing with age and affecting quality of life. While numerous OAB drugs are available, persistence is low. We evaluated evidence published since 2012 to determine if newer drugs provided better efficacy and harm profiles. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Frances C., Weeks, Chandler E., Selph, Shelley S., Blazina, Ian, Holmes, Rebecca S., McDonagh, Marian S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795617/ https://www.ncbi.nlm.nih.gov/pubmed/31346670 http://dx.doi.org/10.1007/s00192-019-04022-8

Ejemplares similares

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Diabetes drugs for nonalcoholic fatty liver disease: a systematic review
por: Blazina, Ian, et al.
Publicado: (2019)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Comment on: update on the management of overactive bladder
por: Staskin, David
Publicado: (2022)

Update on tolterodine extended-release for treatment of overactive bladder
por: Omotosho, Tola, et al.
Publicado: (2010)

Update on the management of overactive bladder: patient considerations and adherence
por: Gomelsky, Alex, et al.
Publicado: (2010)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Urinary Tract Infection in Overactive Bladder: An Update on Pathophysiological Mechanisms
por: Mansfield, Kylie J., et al.
Publicado: (2022)

Drugs for the overactive bladder: are there differences in persistence and compliance?
por: Andersson, Karl-Erik
Publicado: (2017)

Mechanism of traditional Chinese medicine in treating overactive bladder
por: Liao, Yuxiang, et al.
Publicado: (2022)

Studying the potential impact of automated document classification on scheduling a systematic review update
por: Cohen, Aaron M, et al.
Publicado: (2012)

A short review of drug–food interactions of medicines treating overactive bladder syndrome
por: Paśko, Paweł, et al.
Publicado: (2016)

Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom
por: Margulis, Andrea V., et al.
Publicado: (2018)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Drug therapy of overactive bladder - What is coming next?
por: Andersson, Karl-Erik
Publicado: (2015)

Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent
por: Wang, Sheng-Min, et al.
Publicado: (2015)

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions
por: Milsom, Ian, et al.
Publicado: (2020)

Association of Down's syndrome and water fluoride level: a systematic review of the evidence
por: Whiting, Penny, et al.
Publicado: (2001)

A study of the value of requesting information from drug manufacturers for systematic reviews; 9 years of experience from the drug effectiveness review project
por: McDonagh, Marian S., et al.
Publicado: (2018)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Are we there yet? An update on transitional care in rheumatology
por: McDonagh, Janet E., et al.
Publicado: (2018)

Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result
por: Irkilata, Lokman, et al.
Publicado: (2015)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

Recent advances in management of bladder overactivity
por: Smith, Ariana L, et al.
Publicado: (2010)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_86nb0nmh51qp6v470phkle232m